[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412-901-0315", "website": "https://www.lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 56, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 204133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 64, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 195833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 185000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.6794, "open": 0.651, "dayLow": 0.64, "dayHigh": 0.7045, "regularMarketPreviousClose": 0.6794, "regularMarketOpen": 0.651, "regularMarketDayLow": 0.64, "regularMarketDayHigh": 0.7045, "volume": 40358, "regularMarketVolume": 40358, "averageVolume": 57201, "averageVolume10days": 31290, "averageDailyVolume10Day": 31290, "marketCap": 4959574, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 2.71, "priceToSalesTrailing12Months": 11.0306635, "fiftyDayAverage": 0.88144, "twoHundredDayAverage": 1.385665, "currency": "USD", "enterpriseValue": 1246005, "floatShares": 3768833, "sharesOutstanding": 7039850, "sharesShort": 53077, "sharesShortPriorMonth": 25644, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.0075, "heldPercentInsiders": 0.45558998, "heldPercentInstitutions": 0.054819997, "shortRatio": 0.42, "shortPercentOfFloat": 0.0094, "impliedSharesOutstanding": 7039850, "bookValue": 0.519, "priceToBook": 1.3574182, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -4618965, "trailingEps": -0.77, "enterpriseToRevenue": 2.771, "enterpriseToEbitda": -0.263, "52WeekChange": -0.5877193, "SandP52WeekChange": 0.26653707, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LIPO", "underlyingSymbol": "LIPO", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1671460200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d39a1b66-6fea-3b6c-8773-cda09b9e9d93", "messageBoardId": "finmb_35907207", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.7045, "recommendationKey": "none", "totalCash": 3293738, "totalCashPerShare": 0.527, "ebitda": -4744268, "totalDebt": 136594, "quickRatio": 8.631, "currentRatio": 8.899, "totalRevenue": 449617, "debtToEquity": 4.344, "revenuePerShare": 0.075, "returnOnAssets": -0.62268, "returnOnEquity": -1.1813099, "freeCashflow": -1516392, "operatingCashflow": -3150172, "revenueGrowth": -0.2, "operatingMargins": -6.0375896, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-07"}]